Image

A Study Of CS Reducer For Symptomatic Heart Failure With HFpEF And CMD

A Study Of CS Reducer For Symptomatic Heart Failure With HFpEF And CMD

Not Recruiting
18 years and older
All
Phase N/A
  • Technical (Original)
  • Simplified (AI rewritten)

Powered by AI

Overview

To evaluate the effect of CS reducer implantation in patients with HFPEF and CMD on myocardial ischemia, measured by stress myocardial perfusion using cardiovascular magnetic resonance (CMR)

Eligibility

Inclusion Criteria:

  • Age ≥18
  • Enrollment in main CS-reducer HFPEF study IRB# 25-002292

Exclusion Criteria:

  • Metal implants that are not suitable for MRI
  • Inability or unwillingness of individual to give written informed consent.

Study details
    Heart Failure With Preserved Ejection Fraction
    Coronary Microvascular Dysfunction

NCT07093528

Mayo Clinic

5 December 2025

Contact a study center

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.